Inventor
Chundao YANG
Inventor
CN
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes25%
C07BGeneral methods of organic chemistry5%
PatentTitleYear
12,552,7891H-pyrrolo[2,3-c]pyridine compounds and application thereof202612,291,536Crystal form of Wee1 inhibitor compound and use thereof202512,180,184Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereof202411,613,545Macrocyclic compound serving as Wee1 inhibitor and applications thereof202311,384,065Heterocyclic compound as CSF-1R inhibitor and use thereof202211,299,475Prostacyclin receptor agonist202211,230,549Quinolino-pyrrolidin-2-one derivative and application thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022Patents assigned to MEDSHINE DISCOVERY INC (3)· patent assignee history
2022–2026Based in CN· patent location history
2023–2025Patents assigned to WUXI BIOCITY BIOPHARMACEUTICS CO LTD (3)· patent assignee history
2026Patents assigned to JUMBO DRUG BANK CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MEDSHINE DISCOVERY INC | 3 | 2022 |
| WUXI BIOCITY BIOPHARMACEUTICS CO LTD | 3 | 2023–2025 |
| JUMBO DRUG BANK CO LTD | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 7 | 2022–2026 |